Background-Patients undergoing implantable cardioverter-defibrillator (ICD) implantation are at risk of postprocedural complications. However, we do not have a risk stratification schema to identify patients at high and low risk of adverse events. Methods and Results-We analyzed data from 268 701 ICD implants submitted to the ICD Registry and developed logistic regression models to identify variables most strongly associated with the risk of acute complications and/or in-hospital death. Overall, 3.2% of the population experienced an adverse event. A simple risk score consisting of 10 readily available variables successfully identified patients at high and low risk of complications. The variables included in the score and assigned points included: age Ն70 years (1 point), female (2 points), New York Heart Association class III (1 point) or IV (3 points), atrial fibrillation (1 point), prior valve surgery (3 points), chronic lung disease (2 points), blood urea nitrogen Ͼ30 (2 points), reimplantation for reasons other than battery change (6 points), ICD type dual chamber (2 points) or biventricular (4 points), and nonelective ICD implant (3 points). The risk of any in-hospital complication increased from 0.6% among patients with a score of Յ5 (8.4% of the population) to 8.4% among patients with Ն19 risk points (3.9% of the population). Conclusions-A simple risk score consisting of readily available clinical variables can identify high-and low-risk subsets of patients undergoing ICD implantation. This information can guide the physician in patient selection and determining the intensity of care required post procedure.
I mplantable cardioverter-defibrillators (ICDs) improve cardiac and overall survival in selected patients who have increased risk of sudden cardiac death. [1] [2] [3] [4] [5] Expanding indications for prophylactic device implantation have led to an increase in numbers of implants over the last decade. 6 Despite the fact that technological advances have reduced the complexity of device implantation, the procedure carries a significant risk of complications. [3] [4] [5] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] Procedural complications are associated with considerable patient morbidity and mortality, increased hospital length of stay, and increased costs. 17 
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Because of the small but important risk of postprocedural complications, implanting physicians frequently admit patients to medical units that provide a high level of postprocedural care. Nevertheless, most patients have uncomplicated courses. Potentially, patients at very low risk for procedural complications could be monitored in a lower-intensity-care setting or be discharged to home on the day of the procedure, conserving healthcare resources without compromising patient safety. Pres-sure to implement this strategy has been reinforced by policy decisions by the Center for Medicare and Medicaid Services, stating that uncomplicated device-implant patients should be designated as outpatients rather than inpatients, with substantially reduced hospital reimbursement. 18 Nevertheless, we do not have the risk-stratification schema necessary to accurately classify patients at high and low risk of adverse events.
Since 2006, the National Cardiovascular Data Registry has prospectively gathered data on patients undergoing ICD implantation. The registry captures detailed information about patients undergoing ICD implantation, as well as in-hospital procedural complications. We sought to use information available before the implantation to develop predictive models and simple risk scores suitable for characterizing patients' risks of acute procedural complications or inhospital death. This information could identify a low-risk cohort of patients suitable for a reduced intensity of postprocedural observation or possibly same-day hospital discharge. In addition, these models could identify patients for whom the risk of ICD implantation might outweigh its long-term benefit.
Methods Data
The Implantable Cardioverter-Defibrillator Registry (ICDR) is a national database of ICD implants that was initiated as a mandate from the Center for Medicare and Medicaid Services to track ICD implantation demographics, indications, and outcomes (http://www.ncdr.com/webncdr/ICD). The registry collects Ͼ130 data elements at the time of initial ICD implantation, device upgrade, and device replacement. Although data entry is mandated only for patients receiving Medicare or Medicaid benefits undergoing device implantation for primary prevention of sudden cardiac death, 1143 hospitals (88% of participating sites) submitted data for all ICD implantations at their institutions for some or all of the reporting period. 19 Data are entered by hospital personnel, and the data are only included in the analytic file if hospitals achieve Ͼ95% completeness of specific data elements. In addition, a subset of hospitals is randomly identified for on-site review to evaluate data accuracy.
The cohort of the present study comprises patients undergoing ICD implantation from 1300 centers entering data between January 1, 2006, and June 30, 2008. We excluded patients requiring thoracotomy for device implantation because these represent a minority of patients with known greater procedure-related morbidity. Because the registry is limited to in-hospital outcomes, we could not identify all patients who underwent repeat ICD implantation during the study period. Accordingly, each hospitalization with an ICD implantation was evaluated as a separate encounter.
Candidate Variables
We identified 29 variables captured by the registry that would be suitable for the risk model (Table 1) . These variables included admission patient characteristics, history and risk factors, indications for ICD implantation, diagnostic studies, and device type. Information about periprocedural medications (notably anticoagulant/antiplatelet therapy) was not available for analysis, but it is likely that the variables "previous valvular surgery" and "atrial fibrillation/atrial flutter" in part identified patients treated with anticoagulant therapy.
Outcomes
The primary outcome was the occurrence of any in-hospital adverse event, including in-hospital death ( Table 2) . Because the registry is limited to the hospital stay of the ICD implantation, complications that occurred after hospital discharge were not included in these data. Patient death was defined as any death occurring during the index hospital stay.
Statistical Analysis
We examined unadjusted differences in patient characteristics, history, and risk factors, indications for ICD implantation, diagnostic studies, and device type among admissions with and without an adverse event using 2 test for categorical variables. A P value Ͻ0.05 for 2 test was considered statistically significant. To identify the candidate variables most strongly associated with in-hospital complications or death, the study cohort was randomly separated into 2 equally sized cohorts. The first was used to develop the models (referred to as the derivation cohort), and the second was used to validate the models (referred to as validation cohort).
We first developed a risk model for predicting adverse events, including in-hospital death. To accomplish this, we performed multivariable logistic regression analysis with stepwise selection method (entry P value ϭ0.15 and retention P value ϭ0.05). Thresholds for categorizing continuous variables were determined graphically. For all variables except left ventricular ejection fraction, the rate of missing values was Ͻ1%. Accordingly, for categorical variables with yes/no responses, missing data were assumed to represent a no response. For left ventricular ejection fraction, we imputed the median value for the entire cohort and created a dummy variable indicating whether left ventricular ejection fraction was missing. Model discrimination and calibration were evaluated by C and Hosmer-Lemeshow statistics. Low 2 values and high corresponding P values for the Hosmer-Lemeshow statistic indicate adequate model calibration. 20 In the validation cohort, we further assessed model performance by calculating overfitting indices, predictive ability, C-statistic, and Hosmer-Lemeshow statistic. Multicollinearity was excluded through examination of Pearson correlation coefficients and variance inflation factors. Repeating analyses excluding records with missing values did not substantively change our findings.
We identified variables for inclusion in a simple risk score for ICD complications based on their relative contribution in the logistic regression model. Variables were ranked by their Wald 2 , and those with the least contribution were removed from the model until we reached 10 variables that captured Ͼ90% of the information from the full multivariable model (evaluated as the ratio of the global 2 statistic from the reduced compared with the full model). 21 For each patient, the ICD complication risk score was calculated as the simple arithmetic sum of point values assigned to each risk factor on the basis of the multivariable-adjusted risk relationship. Each variable was assigned a numeric value proportional to its associated ␤ coefficient. Differences in complication rates across risk scores were assessed using the 2 test for trend. We evaluated the performance of risk score in the validation cohort.
Second, we developed a risk model for the end point of in-hospital death alone using a similar methodology. To develop a simple risk score for the outcome of in-hospital death, we ranked variables by their Wald 2 , and removed variables until we reached 7 variables that captured Ͼ90% of the information of the full model. Each variable was assigned a numeric value proportional to its associated ␤ coefficient. We then evaluated the performance of the model and risk score in the validation cohort. 21, 22 Multicollinearity was evaluated through examination of Pearson correlation coefficients and variance inflation factors. Blood urea nitrogen (BUN) Ͼ30 and creatinine Ͼ2.0 had a high correlation but low variance inflation factor. Accordingly, both variables were retained in the model.
In order to further characterize the utility of these scores in clinical decision making, we repeated the analyses in the subset of patients undergoing elective ICD implantation (indicated in the registry as "admitted for this procedure"). This excluded patients who had been admitted for treatment of comorbid conditions such as heart-failure exacerbation or renal failure. The rationale for exclusion of these patients is that they represented a group of patients at highest risk for complications due to their comorbidities, and the primary indication for hospitalization was not elective implantation of an ICD. In the elective population, risk stratification could help identify which patients would require more intense inpatient hospital care after ICD implantation. All analyses were performed on SAS Version 9.2 (SAS Inc, Cary, NC). The Yale University Human Investigation Committee approved analysis of data from the ICD Registry.
Results

Baseline Patient Population
Overall, information from 273 713 ICD implantations performed at 1300 hospitals were available for analysis. We excluded 5012 implants requiring thoracotomy for lead placement, leaving a final study cohort of 268 701 implants at 1300 participating facilities. The clinical characteristics of this population and the associated rates of adverse events and death alone for the subgroups are listed in Table 1 . The elective ICD cohort was composed of 179 401 implants, representing 66.8% of the study population.
Specific Complications
A total of 8589 acute procedure-related complications or death were observed in 268 701 implantations (3.20%) as detailed in Table 2 . Cardiac arrest occurred in 804 implantations (0.30%). In-hospital death occurred in 1021 implanta- tions (0.38%), of which 712 were classified as cardiac and 309 were classified as noncardiac in origin. The subset of patients who were admitted for reasons other than elective ICD implantation had a significantly higher overall risk of any complication or death (4.58% versus 2.51% for elective ICD admissions, PϽ0.0001) and of in-hospital death alone (0.91% versus 0.12%; PϽ0.0001).
Univariate Predictors of Complications
The bivariate association between candidate variables and procedural complications including in-hospital death or inhospital death alone are listed in Table 1 . Patients were more likely to suffer complications or death if they were older, female, had lower left ventricular ejection fraction, or had a prolonged QRS duration on ECG. Comorbidities associated with a higher rate of complications included a history of nonischemic dilated cardiomyopathy, congestive heart failure, atrial fibrillation or flutter, prior valve surgery, cerebrovascular disease, chronic kidney disease, and chronic lung disease. Increasing procedural complexity was associated with increasing risk of complications, with lowest rates observed among patients who underwent device generator change for device battery depletion or who had a singlechamber ICD implanted. The univariate predictors of inhospital death alone were similar to those of any complications or in-hospital death with 2 exceptions. First, female sex was not associated with a higher risk of death. Second, diabetes mellitus was associated with a higher risk of inhospital mortality.
Risk Score for Adverse Outcomes
The derivation cohort consisted of 134 069 randomly selected implants, and the validation cohort consisted of 134 632 implants. In the derivation cohort, the multivariable stepwise logistic regression model for the end point of any in-hospital adverse event yielded a C-statistic of 0.677 and a Hosmer-Lemeshow goodness-of-fit 2 of 16.38 (Pϭ0.037). Ten variables accounted for Ͼ90% of explained variance and were included in the simple risk score. Variables in the score included age Ն70 years, female sex, New York Heart Association heart-failure class III or IV, atrial fibrillation or flutter, prior valve surgery, device implant for reasons other than generator change, chronic lung disease, BUN Ͼ30 mg/dL, device type, and reason for admission other than elective ICD implantation ( Table 3 ). In the derivation cohort, the multivariable model limited to these 10 variables had a C-statistic of 0.670 with a Hosmer-Lemeshow 2 of 15.36 (Pϭ0.052). In the validation cohort, the model had a C-statistic of 0.668. Overfitting indices (Ϫ0.061, 0.982) indicated a good fit, with predicted risk ranging from 0.7% to 7.3% in the lowest and highest deciles. However, the high Hosmer-Lemeshow 2 of 41.30 (PϽ0.001) suggests poor model calibration.
The risk of any in-hospital complication increased from 0.6% among patients with a score of Յ5 (8.4% of the population) to 8.4% among patients with Ն19 risk points (3.9% of the population). Among patients with a risk score of Յ9 (32.8% of the population), 1.3% experienced a complication. In contrast, among patients with a risk score of Ն15 (11.9% of the population), 5.1% experienced a complication. Among elective ICD implantations (cohort coded as "admitted for this procedure"), the risk of complications or death increased from 0.6% (risk score Յ5) to 8.0% (risk score Ն19). Among patients with a risk score of Յ9 (46.4% of the population), 1.2% experienced a complication. In contrast, among patients with a risk score of Ն15 (10.8% of the population), 5.6% experienced a complication. The distribution of the risk score and the associated risks for any complication or death in the derivation and validation cohorts are displayed in Figure 1 .
Risk Score for In-Hospital Mortality
The multivariable model for the end point of any in-hospital death yielded a C-statistic of 0.851, and a Hosmer-Lemeshow goodness-of-fit 2 of 9.33 (Pϭ0.315). Seven variables accounted for 90% of the global 2 . Therefore, a simple 7-variable, 15-point score was developed in the derivation cohort predicting in-hospital death. These factors included New York Heart Association heart-failure class, history of cardiac arrest, atrial fibrillation or flutter, BUN Ͼ30 mg/dL, serum creatinine level Ͼ2.0 mg/dL, systolic blood pressure Ͻ100 mm Hg, and reason for admission other than elective device implant ( Table 4 ). The multivariable models with these 7 variables had a C-statistic of 0.842 in the derivation cohort and 0.843 in the validation cohort with corresponding Hosmer-Lemeshow 2 s of 12.95 (Pϭ0.073) and 8.35 (Pϭ0.302), respectively. The corresponding C-statistics in the risk score were 0.841 in the derivation cohort and 0.838 in the validation cohort. The distribution of the risk scores for prediction of death during hospitalization in the derivation and validation cohorts are shown in Figure 2 . The risk of in-hospital mortality increased from Ͻ0.1% among patients with a risk score of 0 (19.7% of the population) to 2.4% among patients with a risk score of Ն7 (8.6% of the population).
Discussion
The present study examined data from 268 701 ICD implantations for primary or secondary prevention of sudden cardiac death at 1 of 1300 hospitals. These data are inclusive of the majority of ICD implants in the United States of America over a 2 1 ⁄2 year period, beginning in 2006. Because of the broad participation of hospitals enrolling in this database, the observations from these data should be applicable to patients undergoing ICD implantation in the United States. Significant complications were observed in 3.05% of implantations, and in-hospital death was seen in 0.38%. We developed a simple risk score using 10 preprocedural variables to accurately identify patients at high and low risk of ICD-associated adverse events. In addition, we describe a model for inhospital mortality after ICD implantation consisting of 7 preprocedure clinical parameters associated with in-hospital death. The resulting risk scores could identify patients at high risk of complications both in the overall cohort of ICD implantations as well as in the subset of patients undergoing elective ICD implantation.
The risk of complications or death increased in a nearlinear fashion with increases in the risk score. Accordingly, the score could be employed to prospectively identify patients at high and low risk of adverse events, and this information could then be applied to clinical decision making. Lower-risk patients (for example, patients with a risk score of Յ9) might appropriately be triaged to observation units with a lower nurse-to-patient ratio or even discharged home the same day. On the other hand, higher-risk patients (for example, patients with a risk score Ն13) may benefit from higher-intensity inpatient care or consideration as to whether the procedure should be delayed to allow the patient's status to be optimized. Importantly, the risk score successfully characterized the risk of adverse outcomes in the cohort of patients undergoing elective hospitalization for device placement. Therefore, one can use the score prospectively to identify patients in whom more intense postprocedure care is warranted on the basis of their preprocedure clinical profile.
Prior Studies
The risks of ICD implantation have been well documented in multiple studies, ranging widely from 1% to 19%. [3] [4] [5] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] The present study is concordant with previously reported complication rates. However, these trials have neither identified predictors of risk of ICD implantation nor been used to produce simple risk scores that can be used to prospectively help guide patient care. Investigators from the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial reported a mortality of 1.1% and an overall device-related complication rate of 11.5% in 539 device implantations. In this patient cohort, no clinical factors predicting complications were identified, with the exception of the use of cephalic vein versus subclavian vein access for lead placement. 10 More recent prospective monitored trials with selected patients have reported low prevalence of in-hospital complications ranging from 1% to 5%, [3] [4] [5] with lowest rates found in implantations by high-volume operators. 11 The higher complication rate observed in the present trial may be a result of an unselected population of patients being studied, and the higher representation of Medicare patients compared with other studies.
Reynolds et al examined 30 984 admissions in the Medicare Provider Analysis and Review (MedPAR) database. They documented a complication rate of 10.3%, including mechanical complication of the ICD and hemorrhage/hematoma. The occurrence of a complication was associated with an increased length of stay of 3.4 days and a $7251 increase in hospital costs. 12 More recently, Al-Khatib et al derived a cohort of 8581 patients from Medicare claims files and reported an index complication rate of 10.8%, with a 9.1% rate reported in 2005 (coincident with initiation of the present cohort data analysis). 13 No procedure-related mortality was presented. The higher complication rate reported by Al-Khatib compared with the present study may be explained by differences in the definitions of adverse events as well as a longer (90-day) follow-up period that captured late complications such as hematoma, infection, and lead dislodgement.
The use of anticoagulant and antiplatelet drugs significantly increases risk of device pocket hematoma. 23, 24 The present study did not examine the influence of medications on device implant complications, but did identify a history of prior valvular surgery or atrial fibrillation/atrial flutter as risk factors. It is common practice to discontinue warfarin prior to surgery and to use bridging anticoagulation therapy (most often intravenous heparin) before and after the surgical procedure. Prior investigators have shown that periprocedural heparin use is associated with a 3-fold increase in the risk of pocket hematoma after device implantation. 23 Of interest, despite the high risk of device pocket hematoma in patients receiving clopidogrel therapy, a prior history of percutaneous coronary intervention did not predict device implantation complications.
Limitations
Complications in the ICD Registry database are reported by participating sites, and may be underreported. However, the relatively high rates of reported complications compared with other published data suggest that the prevalence of under reporting of complications was not high. The risk score was developed and validated using data from the ICD Registry. It would be optimal to confirm the utility of the score in a separate cohort of patients. The multivariable model for adverse events had limited discrimination. This may reflect the inherent challenges in predicting an individual patient's risk of complications, but we cannot exclude the presence of significant unmeasured factors that may influence patient risk. Furthermore, the calibration of the models was poor, particularly at the extremes of risk. Nevertheless, the model served its intended purpose in that the risk score provides a simple method to classify an individual patient's risk of complications. Unlike many published studies, the present data only include complications and mortality occurring during the initial hospitalization. Late complications, such as infection that presents after hospital discharge, are not represented. Complications may be underreported in patients who are discharged the same day (particularly those patients undergoing elective device generator changes for battery end of service).
Clinical Implications
Data collection and risk stratification is necessary for proper quality assessment, outcome improvement, and clinical resource management. Although the risk score systems described above do not translate well to the assessment of stable patients undergoing elective ICD implantation, their value in optimizing patient selection, safety, and cost effectiveness for the target populations are well established. The present study proposes application of a system to assist clinicians in identification of patients at risk for procedure-related complications or death with implantation of an ICD. Use of this method will promote more efficient employment of healthcare resources by focusing more intensive postprocedure care only on the patients at higher risk of complications. For lower-risk patients with complication scores Յ9, a lower intensity of postprocedure monitoring including same-day hospital discharge may be appropriate. For high-risk patients with complication scores Ն15 and mortality scores Ն6, knowledge of increased procedure-related risk may change the risk-benefit equation leading to device implantation. Instead of performing device implantation at the end of a complex hospitalization, consideration should be made to cancel or delay the operation for elective readmission until patient status has been optimized. Although these guidelines may be a valuable tool in clinical care, they do not guarantee freedom from complications in lower-risk patients. The ultimate decision making on the level of postoperative care must be assumed by the primary caregiver.
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